Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2007 2
2008 2
2009 4
2010 3
2011 8
2012 9
2013 5
2014 9
2015 8
2016 12
2017 15
2018 12
2019 11
2020 13
2021 15
2022 11
2023 7

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.
Tung NM, Robson ME, Ventz S, Santa-Maria CA, Nanda R, Marcom PK, Shah PD, Ballinger TJ, Yang ES, Vinayak S, Melisko M, Brufsky A, DeMeo M, Jenkins C, Domchek S, D'Andrea A, Lin NU, Hughes ME, Carey LA, Wagle N, Wulf GM, Krop IE, Wolff AC, Winer EP, Garber JE. Tung NM, et al. Among authors: yang es. J Clin Oncol. 2020 Dec 20;38(36):4274-4282. doi: 10.1200/JCO.20.02151. Epub 2020 Oct 29. J Clin Oncol. 2020. PMID: 33119476 Clinical Trial.
A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer.
Gong C, Cheng Z, Yang Y, Shen J, Zhu Y, Ling L, Lin W, Yu Z, Li Z, Tan W, Zheng C, Zheng W, Zhong J, Zhang X, Zeng Y, Liu Q, Huang RS, Komorowski AL, Yang ES, Bertucci F, Ricci F, Orlandi A, Franceschini G, Takabe K, Klimberg S, Ishii N, Toss A, Tan MP, Cherian MA, Song E. Gong C, et al. Among authors: yang es. Sci China Life Sci. 2022 Nov;65(11):2205-2217. doi: 10.1007/s11427-022-2104-3. Epub 2022 May 13. Sci China Life Sci. 2022. PMID: 35579777
Randomized trial of weight loss in primary breast cancer: Impact on body composition, circulating biomarkers and tumor characteristics.
Demark-Wahnefried W, Rogers LQ, Gibson JT, Harada S, Frugé AD, Oster RA, Grizzle WE, Norian LA, Yang ES, Della Manna D, Jones LW, Azrad M, Krontiras H. Demark-Wahnefried W, et al. Among authors: yang es. Int J Cancer. 2020 May 15;146(10):2784-2796. doi: 10.1002/ijc.32637. Epub 2019 Sep 5. Int J Cancer. 2020. PMID: 31442303 Free PMC article. Clinical Trial.
Targeting DNA repair in precision medicine.
Beggs R, Yang ES. Beggs R, et al. Among authors: yang es. Adv Protein Chem Struct Biol. 2019;115:135-155. doi: 10.1016/bs.apcsb.2018.10.005. Epub 2018 Dec 5. Adv Protein Chem Struct Biol. 2019. PMID: 30798930 Review.
Poly(ADP-ribose) polymerase activity and inhibition in cancer.
Dulaney C, Marcrom S, Stanley J, Yang ES. Dulaney C, et al. Among authors: yang es. Semin Cell Dev Biol. 2017 Mar;63:144-153. doi: 10.1016/j.semcdb.2017.01.007. Epub 2017 Jan 10. Semin Cell Dev Biol. 2017. PMID: 28087320 Review.
Discussion of PARP inhibitors in cancer therapy.
Wielgos M, Yang ES. Wielgos M, et al. Among authors: yang es. Pharm Pat Anal. 2013 Nov;2(6):755-66. doi: 10.4155/ppa.13.53. Pharm Pat Anal. 2013. PMID: 24237241 Review.
Epigenetic inactivation of DNA repair in breast cancer.
Nowsheen S, Aziz K, Tran PT, Gorgoulis VG, Yang ES, Georgakilas AG. Nowsheen S, et al. Among authors: yang es. Cancer Lett. 2014 Jan 28;342(2):213-22. doi: 10.1016/j.canlet.2012.05.015. Epub 2012 May 23. Cancer Lett. 2014. PMID: 22634493 Review.
126 results